Aphria (NASDAQ: APHA) stock plunged more than 10% in the pre-market trading session as it reported a loss of C$98 million or C$0.39 per share in the fourth quarter of 2020. However, revenue in the final quarter of 2020 rose 18% year-over to C$152 million.
Q4 results included a non-cash impairment charges of C$64 million, which is largely attributable to measures taken with respect to certain of the company’s international businesses in response to the COVID-19 pandemic.
The Ontario-based cannabis producer transferred its listing from NYSE to NASDAQ with effect from June 8, 2020.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment